Home
ANIX
ANIX News

Latest Anixa Biosciences Inc. (ANIX) News on June 2, 2025

Anixa Biosciences Announces Completion of Enrollment in Phase 1 Trial of Breast Cancer Vaccine

PR Newswire

5 hours ago

Anixa Biosciences Announces Completion of Enrollment in Phase 1 Trial of Breast Cancer Vaccine

Anixa Biosciences CEO Provides Letter to Shareholders Outlining Significant Progress and Advancement Towards Potentially Transformative Milestones

PR Newswire

14 days ago

Anixa Biosciences CEO Provides Letter to Shareholders Outlining Significant Progress and Advancement Towards Potentially Transformative Milestones

Anixa Biosciences Announces Poster Presentation on Ovarian Cancer CAR-T Clinical Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting

PR Newswire

21 days ago

Anixa Biosciences Announces Poster Presentation on Ovarian Cancer CAR-T Clinical Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting

Anixa Biosciences to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference on May 20th

PR Newswire

a month ago

Anixa Biosciences to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference on May 20th

Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for CAR-T Technology, Further Strengthening its Robust Intellectual Property Portfolio

PR Newswire

2 months ago

Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for CAR-T Technology, Further Strengthening its Robust Intellectual Property Portfolio

Is AngioDynamics (ANGO) Outperforming Other Medical Stocks This Year?

Zacks

2 months ago

Is AngioDynamics (ANGO) Outperforming Other Medical Stocks This Year?

ANIX Gets New Patent for Breast Cancer Vaccine Technology, Stock Up

Zacks

2 months ago

ANIX Gets New Patent for Breast Cancer Vaccine Technology, Stock Up

MT Newswires

2 months ago

Sector Update: Health Care

MT Newswires

2 months ago

Anixa Biosciences Shares Rise After Notice of Patent Allowance for Breast Cancer Vaccine

Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for Patent Covering Breast Cancer Vaccine Technology

PR Newswire

2 months ago

Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for Patent Covering Breast Cancer Vaccine Technology

EXCLUSIVE: Anixa Biosciences Receives Key US Patent Nod For Breast Cancer Vaccine Patent

Benzinga

2 months ago

EXCLUSIVE: Anixa Biosciences Receives Key US Patent Nod For Breast Cancer Vaccine Patent

Anixa Biosciences to Present at the Jones Las Vegas Healthcare and Technology Innovation Conference on April 9th

PR Newswire

2 months ago

Anixa Biosciences to Present at the Jones Las Vegas Healthcare and Technology Innovation Conference on April 9th

MT Newswires

2 months ago

Anixa Enters Letter of Intent to Develop Verdi's AI-Guided Cancer Vaccines

Anixa Biosciences Enters Letter of Intent with VERDI Solutions to Develop Artificial Intelligence-Guided Personalized and Off-the-Shelf Cancer Vaccines

PR Newswire

2 months ago

Anixa Biosciences Enters Letter of Intent with VERDI Solutions to Develop Artificial Intelligence-Guided Personalized and Off-the-Shelf Cancer Vaccines

EXCLUSIVE: Anixa Biosciences Inks Letter of Intent with Austria-Based VERDI Solutions To Develop AI-Guided Personalized Cancer Vaccines

Benzinga

2 months ago

EXCLUSIVE: Anixa Biosciences Inks Letter of Intent with Austria-Based VERDI Solutions To Develop AI-Guided Personalized Cancer Vaccines

MT Newswires

2 months ago

Anixa Biosciences Receives US Patent Notice of Allowance for Potential Ovarian Cancer Vaccine

Anixa Biosciences Receives Notice of Allowance from USPTO for Ovarian Cancer Vaccine

PR Newswire

2 months ago

Anixa Biosciences Receives Notice of Allowance from USPTO for Ovarian Cancer Vaccine

EXCLUSIVE: Anixa Biosciences Poised To Receive US Patent For Ovarian Cancer Vaccine

Benzinga

2 months ago

EXCLUSIVE: Anixa Biosciences Poised To Receive US Patent For Ovarian Cancer Vaccine

Anixa Biosciences CEO to Present at the 2025 CAGLA NeauxCancer Conference on March 28th

PR Newswire

3 months ago

Anixa Biosciences CEO to Present at the 2025 CAGLA NeauxCancer Conference on March 28th

Is Gilead Sciences (GILD) Stock Outpacing Its Medical Peers This Year?

Zacks

3 months ago

Is Gilead Sciences (GILD) Stock Outpacing Its Medical Peers This Year?

Anixa Biosciences 2025 Annual Meeting of Stockholders to Include Investor Presentation Open to All Interested Parties

PR Newswire

3 months ago

Anixa Biosciences 2025 Annual Meeting of Stockholders to Include Investor Presentation Open to All Interested Parties

Anixa Biosciences Announces Chief Development Officer Dr. Pam Garzone to Speak at the Alliance for Cancer Gene Therapy Summit 2025 on March 19th

PR Newswire

3 months ago

Anixa Biosciences Announces Chief Development Officer Dr. Pam Garzone to Speak at the Alliance for Cancer Gene Therapy Summit 2025 on March 19th

Spotlight On February 2025's Promising Penny Stocks

Simply Wall St.

3 months ago

Spotlight On February 2025's Promising Penny Stocks

Anixa Biosciences and Moffitt Cancer Center Complete Dosing in Third Cohort in Ovarian Cancer CAR-T Clinical Trial

PR Newswire

3 months ago

Anixa Biosciences and Moffitt Cancer Center Complete Dosing in Third Cohort in Ovarian Cancer CAR-T Clinical Trial

Anixa Biosciences' Breast Cancer Vaccine was Featured on Fox News' "America Reports"

PR Newswire

3 months ago

Anixa Biosciences' Breast Cancer Vaccine was Featured on Fox News' "America Reports"

Anixa Biosciences Featured in Breaking Cancer News Article on Novel CAR-T Therapy for Ovarian Cancer

PR Newswire

3 months ago

Anixa Biosciences Featured in Breaking Cancer News Article on Novel CAR-T Therapy for Ovarian Cancer

Is Agenus (AGEN) Stock Outpacing Its Medical Peers This Year?

Zacks

3 months ago

Is Agenus (AGEN) Stock Outpacing Its Medical Peers This Year?

Anixa Biosciences Announces Approval of Protocol Amendment for Ovarian Cancer CAR-T Clinical Trial

PR Newswire

3 months ago

Anixa Biosciences Announces Approval of Protocol Amendment for Ovarian Cancer CAR-T Clinical Trial

Anixa Biosciences Chairman and CEO Discusses Pioneering CAR-T Cell Therapy and Breast Cancer Vaccine in Alpha Wolf Trading Interview

PR Newswire

4 months ago

Anixa Biosciences Chairman and CEO Discusses Pioneering CAR-T Cell Therapy and Breast Cancer Vaccine in Alpha Wolf Trading Interview

Anixa Biosciences to Present at the 18th Annual European Life Sciences CEO Forum

PR Newswire

4 months ago

Anixa Biosciences to Present at the 18th Annual European Life Sciences CEO Forum

Anixa Biosciences' Chairman & CEO Dr. Amit Kumar Featured on CW39's H-Town Live to Discuss the Future of Breast Cancer Prevention

PR Newswire

4 months ago

Anixa Biosciences' Chairman & CEO Dr. Amit Kumar Featured on CW39's H-Town Live to Discuss the Future of Breast Cancer Prevention

Anixa Biosciences CEO Provides Letter to Shareholders

PR Newswire

4 months ago

Anixa Biosciences CEO Provides Letter to Shareholders

Anixa Biosciences Leads 3 Promising Penny Stocks On US Exchanges

Simply Wall St.

5 months ago

Anixa Biosciences Leads 3 Promising Penny Stocks On US Exchanges

Anixa Biosciences (NASDAQ:ANIX) Is In A Good Position To Deliver On Growth Plans

Simply Wall St.

5 months ago

Anixa Biosciences (NASDAQ:ANIX) Is In A Good Position To Deliver On Growth Plans

ACCESSWIRE

6 months ago

iAccess Alpha's Buyside Best Ideas Virtual Winter Conference December 10-11, 2024

Anixa Biosciences to Present at the iAccess Alpha Virtual Best Ideas Winter Conference 2024 on December 10

PR Newswire

6 months ago

Anixa Biosciences to Present at the iAccess Alpha Virtual Best Ideas Winter Conference 2024 on December 10

Anixa Biosciences, Inc. (NASDAQ:ANIX) Shares Could Be 20% Below Their Intrinsic Value Estimate

Simply Wall St.

6 months ago

Anixa Biosciences, Inc. (NASDAQ:ANIX) Shares Could Be 20% Below Their Intrinsic Value Estimate

MT Newswires

6 months ago

Anixa Biosciences' Board Approves Bitcoin Purchase as Treasury Reserve Asset

Anixa Biosciences Initiates Dosing in Third Cohort in its Ovarian Cancer CAR-T Clinical Trial

PR Newswire

6 months ago

Anixa Biosciences Initiates Dosing in Third Cohort in its Ovarian Cancer CAR-T Clinical Trial

Anixa Biosciences and Cleveland Clinic Present New Updated Positive Data from Phase 1 Study of Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting

PR Newswire

7 months ago

Anixa Biosciences and Cleveland Clinic Present New Updated Positive Data from Phase 1 Study of Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting

Anixa Biosciences Announces Timing of Public Release of Data from the Phase 1 Study of its Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting

PR Newswire

7 months ago

Anixa Biosciences Announces Timing of Public Release of Data from the Phase 1 Study of its Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting

Anixa Biosciences to Present at the Sidoti Micro-Cap Virtual Conference on November 13 & 14, 2024

PR Newswire

7 months ago

Anixa Biosciences to Present at the Sidoti Micro-Cap Virtual Conference on November 13 & 14, 2024

Anixa Biosciences and Cleveland Clinic to Present Additional Data from Phase 1 Study of Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting

PR Newswire

7 months ago

Anixa Biosciences and Cleveland Clinic to Present Additional Data from Phase 1 Study of Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting

US Penny Stocks To Consider In October 2024

Simply Wall St.

7 months ago

US Penny Stocks To Consider In October 2024

Anixa Biosciences administers second CAR-T dose in ovarian cancer trial

Clinical Trials Arena

8 months ago

Anixa Biosciences administers second CAR-T dose in ovarian cancer trial

Anixa Biosciences Announces Second Dose Administered to Patient in Ovarian Cancer CAR-T Clinical Trial

PR Newswire

8 months ago

Anixa Biosciences Announces Second Dose Administered to Patient in Ovarian Cancer CAR-T Clinical Trial

Anixa Biosciences Appoints Suyasha Gupta as Senior Director of Clinical Development

PR Newswire

8 months ago

Anixa Biosciences Appoints Suyasha Gupta as Senior Director of Clinical Development

Anixa Biosciences Announces Submission of Protocol Amendment for CAR-T Trial

PR Newswire

8 months ago

Anixa Biosciences Announces Submission of Protocol Amendment for CAR-T Trial

Anixa announces plans to launch Phase II breast cancer vaccine trial

Clinical Trials Arena

8 months ago

Anixa announces plans to launch Phase II breast cancer vaccine trial

Anixa Biosciences Unveils Phase 2 Study Plan for Breast Cancer Vaccine

PR Newswire

8 months ago

Anixa Biosciences Unveils Phase 2 Study Plan for Breast Cancer Vaccine

Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Therapy at the Ovarian Cancer Research Alliance's International Gynecologic Cancer Conference

PR Newswire

8 months ago

Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Therapy at the Ovarian Cancer Research Alliance's International Gynecologic Cancer Conference

Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Therapy at the Rivkin Center-AACR 15th Biennial Ovarian Cancer Research Symposium

PR Newswire

9 months ago

Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Therapy at the Rivkin Center-AACR 15th Biennial Ovarian Cancer Research Symposium

Anixa Biosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference

PR Newswire

9 months ago

Anixa Biosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Amicus (FOLD) Up as Q2 Earnings & Sales Top, '24 View Updated

Zacks

10 months ago

Amicus (FOLD) Up as Q2 Earnings & Sales Top, '24 View Updated

Intra-Cellular (ITCI) Q2 Loss Narrower Than Expected, Sales Beat

Zacks

10 months ago

Intra-Cellular (ITCI) Q2 Loss Narrower Than Expected, Sales Beat

Acadia (ACAD) Q2 Earnings Beat, Product Sales Drive Revenues

Zacks

10 months ago

Acadia (ACAD) Q2 Earnings Beat, Product Sales Drive Revenues

Zoetis (ZTS) Q2 Earnings & Revenues Beat, '24 Outlook Raised

Zacks

10 months ago

Zoetis (ZTS) Q2 Earnings & Revenues Beat, '24 Outlook Raised

Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Clinical Trial at the International Gynecologic Cancer Society 2024 Annual Meeting

PR Newswire

10 months ago

Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Clinical Trial at the International Gynecologic Cancer Society 2024 Annual Meeting

We're Hopeful That Anixa Biosciences (NASDAQ:ANIX) Will Use Its Cash Wisely

Simply Wall St.

10 months ago

We're Hopeful That Anixa Biosciences (NASDAQ:ANIX) Will Use Its Cash Wisely

MT Newswires

10 months ago

Anixa Partner Gets FDA Nod for Second CAR-T Treatment to Ovarian Cancer Patient

Anixa Biosciences Announces FDA Approval of Individual Patient IND for its Ovarian Cancer CAR-T Therapy

PR Newswire

10 months ago

Anixa Biosciences Announces FDA Approval of Individual Patient IND for its Ovarian Cancer CAR-T Therapy

EXCLUSIVE: FDA Approves Anixa Biosciences' Individual Patient Trial Application For Ovarian Cancer CAR-T Therapy

Benzinga

10 months ago

EXCLUSIVE: FDA Approves Anixa Biosciences' Individual Patient Trial Application For Ovarian Cancer CAR-T Therapy

MT Newswires

a year ago

Anixa Biosciences Receives Patent for Breast Cancer Vaccine Technology in Japan

Anixa Biosciences Announces Japanese Patent on Breast Cancer Vaccine Technology

PR Newswire

a year ago

Anixa Biosciences Announces Japanese Patent on Breast Cancer Vaccine Technology

MT Newswires

a year ago

Anixa Biosciences Launches $5 Million Share Buyback Program; Shares Jump

Anixa Biosciences Announces $5 Million Share Repurchase Program

PR Newswire

a year ago

Anixa Biosciences Announces $5 Million Share Repurchase Program

EXCLUSIVE: Anixa Biosciences Finds Stock Undervalued, Launches $5M Stock Buyback Program

Benzinga

a year ago

EXCLUSIVE: Anixa Biosciences Finds Stock Undervalued, Launches $5M Stock Buyback Program

MT Newswires

a year ago

Anixa Biosciences Says Sixth Patient Treated in Phase 1 Ovarian Cancer Study

Anixa Biosciences Treats Sixth Patient in its Ovarian Cancer CAR-T Clinical Trial

PR Newswire

a year ago

Anixa Biosciences Treats Sixth Patient in its Ovarian Cancer CAR-T Clinical Trial

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers

GOBankingRates

a year ago

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers

Bumrah delivers as India beat Pakistan in low-scoring thriller

AFP

a year ago

Bumrah delivers as India beat Pakistan in low-scoring thriller

Italy beat Bosnia in final Euros warm-up

AFP

a year ago

Italy beat Bosnia in final Euros warm-up

Macron Calls French Legislative Election After Far-Right Surge

Bloomberg

a year ago

Macron Calls French Legislative Election After Far-Right Surge

Trump loyalists proud to support 'felon' at Las Vegas rally

AFP

a year ago

Trump loyalists proud to support 'felon' at Las Vegas rally

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

Business Insider

a year ago

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

The Best Woody Perfume For Women

Insider Monkey

a year ago

The Best Woody Perfume For Women

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

Reuters

a year ago

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

Anixa Biosciences Commences Treatment of Fifth Patient in Ovarian Cancer CAR-T Clinical Trial

PR Newswire

a year ago

Anixa Biosciences Commences Treatment of Fifth Patient in Ovarian Cancer CAR-T Clinical Trial

Anixa expands cancer vaccine collaboration with Cleveland Clinic

Pharmaceutical Technology

a year ago

Anixa expands cancer vaccine collaboration with Cleveland Clinic

Anixa Biosciences Expands Partnership with Cleveland Clinic to Develop Additional Cancer Vaccines

PR Newswire

a year ago

Anixa Biosciences Expands Partnership with Cleveland Clinic to Develop Additional Cancer Vaccines

Sidoti Events, LLC's Virtual May Micro-Cap Conference

ACCESSWIRE

a year ago

Sidoti Events, LLC's Virtual May Micro-Cap Conference

Anixa Biosciences CEO Featured on "Target: Cancer Podcast" by Oncologist Dr. Sanjay Juneja

PR Newswire

a year ago

Anixa Biosciences CEO Featured on "Target: Cancer Podcast" by Oncologist Dr. Sanjay Juneja

Anixa Biosciences to Participate in the Sidoti Micro-Cap Virtual Conference on May 8 & 9, 2024

PR Newswire

a year ago

Anixa Biosciences to Participate in the Sidoti Micro-Cap Virtual Conference on May 8 & 9, 2024

Anixa Biosciences Welcomes Celebrity Oncologist Dr. Sanjay Juneja to its Cancer Business Advisory Board

PR Newswire

a year ago

Anixa Biosciences Welcomes Celebrity Oncologist Dr. Sanjay Juneja to its Cancer Business Advisory Board

Anixa Biosciences 2024 Annual Meeting of Stockholders to Include Investor Presentation Open to All Interested Parties

PR Newswire

a year ago

Anixa Biosciences 2024 Annual Meeting of Stockholders to Include Investor Presentation Open to All Interested Parties

Anixa Biosciences Announces Presentation at 24th Annual World Vaccine Congress

PR Newswire

a year ago

Anixa Biosciences Announces Presentation at 24th Annual World Vaccine Congress

We Think Anixa Biosciences (NASDAQ:ANIX) Can Easily Afford To Drive Business Growth

Simply Wall St.

a year ago

We Think Anixa Biosciences (NASDAQ:ANIX) Can Easily Afford To Drive Business Growth

Anixa Biosciences Initiates Dosing in Second Cohort of Ovarian Cancer CAR-T Clinical Trial

PR Newswire

a year ago

Anixa Biosciences Initiates Dosing in Second Cohort of Ovarian Cancer CAR-T Clinical Trial

Anixa Biosciences Announces Participation in 2024 NeauxCancer Oncology Conference

PR Newswire

a year ago

Anixa Biosciences Announces Participation in 2024 NeauxCancer Oncology Conference

Panacea Financial Named Exclusive Practice Finance Provider for American Dental Association Members across the United States

PR Newswire

a year ago

Panacea Financial Named Exclusive Practice Finance Provider for American Dental Association Members across the United States

Desktop Metal Intensifies Cost Reduction Plan and Ongoing Strategic Business Review to Accelerate Path to Profitability

Business Wire

a year ago

Desktop Metal Intensifies Cost Reduction Plan and Ongoing Strategic Business Review to Accelerate Path to Profitability

Anixa Biosciences Announces Japanese Patent on Ovarian Cancer Vaccine Technology

PR Newswire

a year ago

Anixa Biosciences Announces Japanese Patent on Ovarian Cancer Vaccine Technology

RE/MAX NATIONAL HOUSING REPORT FOR DECEMBER 2023

PR Newswire

a year ago

RE/MAX NATIONAL HOUSING REPORT FOR DECEMBER 2023

Sidoti Events, LLC's Virtual January Micro-Cap Conference

ACCESSWIRE

a year ago

Sidoti Events, LLC's Virtual January Micro-Cap Conference

Build-A-Bear Introduces SKOOSHERZ, the Newest Huggable Furry Friend Collection

PR Newswire

a year ago

Build-A-Bear Introduces SKOOSHERZ, the Newest Huggable Furry Friend Collection

Insider Stock Buying Reaches US$2.17m On Bankwell Financial Group

Simply Wall St.

a year ago

Insider Stock Buying Reaches US$2.17m On Bankwell Financial Group

Amarin (AMRN) Stock Rises on Stellar Q4 Preliminary Results

Zacks

a year ago

Amarin (AMRN) Stock Rises on Stellar Q4 Preliminary Results

Anixa Biosciences to Present at Sidoti Micro-Cap Virtual Conference on January 17, 2024

PR Newswire

a year ago

Anixa Biosciences to Present at Sidoti Micro-Cap Virtual Conference on January 17, 2024

Bit Digital, Inc. Announces Upsized Customer Contract for Bit Digital AI

PR Newswire

a year ago

Bit Digital, Inc. Announces Upsized Customer Contract for Bit Digital AI

Compugen to Receive $10 Million Milestone Payment Following Dosing of First Patient in AstraZeneca Phase 3 Rilvegostomig Trial in Biliary Tract Cancer

PR Newswire

a year ago

Compugen to Receive $10 Million Milestone Payment Following Dosing of First Patient in AstraZeneca Phase 3 Rilvegostomig Trial in Biliary Tract Cancer

Share on Social Networks: